|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiorenal SyndromeType 1 May Be Immunologically Mediated: A Pilot Evaluation ofMonocyte Apoptosis显示文摘 | Virzì GM Torregrossa R Cruz DN | 2012 | Cardiorenal Med2012，2，1： | 1 |
| 2 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanceed epithelial ovarian cancer:multi-institutional phase-Ⅱtrial显示文摘 | Deraco M Kusamura S VirzìS | 2011 | Gynecol Oncol2011，122，2： | 1 |
| 3 | Treatment of combined endodontic-periodontic lesions using guided tissue regeneration:clinical case and histology显示文摘 | Ghezzi C VirzìM Schupbach P | 2012 | Int J Periodontics Restorative Dent2012，32，4： | 1 |
| 4 | Cardiorenal syndrome type 1 may be immunologically mediated:a pilot evaluation of monocyte apoptosis显示文摘 | Virzì GM Torregrossa R Cruz DN | | 0，，01： | 1 |
| 5 | Cardiorenal syndrome type 5:in vitro cytotoxicity effects on renal tubular cell and inflammatory profile显示文摘 | Brocca A1 VirzìGM2 Pasqualin C | 2015 | Anal Cell Pathol(Amst)2015，2015，46： | 1 |
| 6 | Heart-kidney crosstalk and role ofhumoral signaling in critical illness显示文摘 | Virzì G Day S de Cal M | 2014 | Crit Care2014，18，1： | 1 |
| 7 | Oxidative stress:dual pathway induction in cardiorenal syndrome type 1 pathogenesis显示文摘 | VirzìGM Clementi A de Cal M | 2015 | Oxid Med Cell Longev2015，2015，39： | 1 |
| 8 | Heart-kidney Crosstalk and role of humoral signaling in criticalillness显示文摘 | VirzìG Day S de Cal M | 2014 | Crit Care2014，18，1： | 1 |
| 9 | Liver involvement in the course of thymoma-associated multiorgan autoimmunity:The first histological description显示文摘To the Editor:Thymoma-associated multiorgan autoimmunity(TAMA)is a rare paraneoplastic syndrome described in patients with thymoma and characterized by multiorgan failure and graft-versus-host dis-ease(GVHD)like pathology affecting the skin,the gastrointestinal tract,and the liver.To date,only 21 cases are reported in liter-ature[1],with some patients presenting gastrointestinal and hep-atic manifestations,mainly colitis,diarrhea,and abnormal liver en-zymes,but the hepatic involvement has not been histologically characterized yet. | Fabrizio Citarella Umberto Vespasiani-Gentilucci Anna Crescenzi Antonella Bianchi Vladimir Virzì Giuseppe Tonini | 2022 | Hepatobiliary & Pancreatic Diseases International2022，21，1： | 0 |
| 10 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial显示文摘 | Marcello Deraco Shigeki Kusamura Salvatore Virzì Francesco Puccio Antonio Macrì Ciro Famulari Massimiliano Solazzo Serena Bonomi Domenico Rosario Iusco Dario Baratti | 2011 | Gynecologic Oncology2011，，2： | 1 |
| 11 | Peritoneal carcinomatosis显示文摘Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity.The occurrence of peritoneal carcinomatosis(PC)has been shown to significantly decrease overall survival in patients with liver and/or extraperitoneal metastases from gastrointestinal cancer.During the last three decades,the understanding of the biology and pathways of dissemination of tumors with intraperitoneal spread,and the understanding of the protective function of the peritoneal barrier against tumoral seeding,has prompted the concept that PC is a loco-regional disease:in absence of other systemic metastases,multimodal approaches combining aggressive cytoreductive surgery,intraperitoneal hyperthermic chemotherapy and systemic chemotherapy have been proposed and are actually considered promising methods to improve loco-regional control of the disease,and ultimately to increase survival.The aim of this review article is to present the evidence on treatment of PC in different tumors,in order to provide patients with a proper surgical and multidisciplinary treatment focused on optimal control of their locoregional disease. | Federico Coccolini Federico Gheza Marco Lotti Salvatore Virzì Domenico Iusco Claudio Ghermandi Rita Melotti Gianluca Baiocchi Stefano Maria Giulini Luca Ansaloni Fausto Catena | 2013 | World Journal of Gastroenterology2013，19，41： | 9 |
| 12 | Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry)显示文摘 | Tullio Palmerini Antonio Marzocchi Cinzia Marrozzini Paolo Ortolani Francesco Saia Carlo Savini Letizia Bacchi-Reggiani Silvia Gianstefani Santo Virzì Francesca Manara Meron Kiros Weldeab Giuseppe Marinelli Roberto Di Bartolomeo Angelo Branzi | 2006 | The American Journal of Cardiology2006，，1： | 1 |
| 13 | Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.显示文摘 | F. Cavaliere M. De Simone S. Virzì M. Deraco C.R. Rossi A. Garofalo F. Di Filippo D. Giannarelli M. Vaira M. Valle P. Pilati P. Perri M. La Pinta I. Monsellato F. Guadagni | 2010 | European Journal of Surgical Oncology2010，，2： | 1 |
| 14 | Neutrophil gelatinase-associated lipocalin does not predict acute kidney injury in heart failure显示文摘BACKGROUND Acute cardiorenal syndrome type 1(CRS-1)is defined by a rapid cardiac dysfunction leading to acute kidney injury(AKI).Neutrophil gelatinaseassociated lipocalin(NGAL)is expressed on the surface of human neutrophils and epithelial cells,such as renal tubule cells,and its serum(sNGAL)and urinary have been used to predict AKI in different clinical settings.AIM To characterize CRS-1 in a cohort of patients with acute heart diseases,evaluating the potentiality of sNGAL as an early marker of CRS-1.METHODS We performed a retrospective cohort,multi-centre study.From January 2010 to December 2011,we recruited 202 adult patients admitted to the coronary intensive care unit(CICU)with a diagnosis of acute heart failure or acute coronary syndrome.We monitored the renal function to evaluate CRS-1 development and measured sNGAL levels within 24 h and after 72 h of CICU admission.RESULTS Overall,enrolled patients were hemodynamically stable with a mean arterial pressure of 92(82-107)mmHg,55/202(27.2%)of the patients developed CRS-1,but none of them required dialysis.Neither the NGAL delta value(AUC 0.40,95%CI:0.25-0.55)nor the NGAL peak(AUC 0.45,95%CI:0.36-0.54)or NGAL cutoff(≥140 ng/mL)values were statistically significant between the two groups(CRS-1 vs no-CRS1 patients).The area under the ROC curve for the prediction of CRS-1 was 0.40(95%CI:0.25-0.55)for the delta NGAL value and 0.45(95%CI:0.36-0.54)for the NGAL peak value.Finally,in multivariate analysis,the risk of developing CRS-1 was correlated with age>60 years,urea nitrogen at admission and 24 h-urine output(AUC 0.83,SE=60.5%SP=93%),while sNGAL was not significantly correlated.CONCLUSION In our population,sNGAL does not predict CRS-1,probably as a consequence of the mild renal injury and the low severity of heart disease.So,these data might suggest that patient selection should be taken into account when considering the utility of NGAL measurement as a biomarker of kidney damage. | Fiorenza Ferrari Elisa Scalzotto Pasquale Esposito Sara Samoni Flavio Mistrorigo Lilia Maria Rizo Topete Massimo De Cal Grazia Maria Virzì Valentina Corradi Rossella Torregrossa Roberto Valle Stefania Bianzina Nadia Aspromonte Matteo Floris Alessandro Fontanelli Alessandra Brendolan Claudio Ronco | 2020 | World Journal of Clinical Cases2020，8，9： | 3 |
您所在的机构暂未开通此部分的功能，请联系管理员